Source comparison
Melanotan-2 Oral vs Injectable: Side-by-Side Comparison
The table below summarizes the practical differences between Melanotan-2 oral vs injectable administration across the variables that matter most in research design: bioavailability, dosing, cost-efficiency, and reproducibility. Injectable (subcutaneous) 92–98%
This comparison does not assign a generated winner or score.
- The table below summarizes the practical differences between Melanotan-2 oral vs injectable administration across the variables that matter most in research design: bioavailability, dosing, cost-efficiency, and reproducibility.
- Injectable (subcutaneous)
- 92–98%
- 250–500 mcg daily (loading), 250 mcg 2–3× weekly (maintenance)
- Visible pigmentation within 72–96 hours; full effect 2–3 weeks
- $0.50–1.50 per dose (10mg vial = 20–40 doses)
- High. Predictable pharmacokinetics, tight dose-response curve
- Gold standard for research. Reliable absorption, established safety profile, dose precision
- Oral (experimental)
- 1.8–5%
- 5–20 mg daily (estimates from anecdotal reports; no standardized protocol)
- Variable; 7–14 days reported, inconsistent maintenance
- $5–15 per dose (requires 10–40× more peptide per equivalent effect)
- Low. Variable gastric degradation, unpredictable absorption, no validated formulation
- Not recommended for controlled studies. Poor bioavailability, no peer-reviewed dosing data, cost-prohibitive